A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2022-12-23
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the levels of study drug called LY3502970 in
the blood stream when administered alone and in combination with cyclosporine in healthy
participants. The study will also evaluate the safety and tolerability of LY3502970 in
healthy participants. This study will last up to approximately 76 days for each participant.